Revenue Update on AxoGen(NASDAQ:AXGN)

AxoGen(NASDAQ:AXGN) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 3, 2016. Company reported revenue of $10.38M. Analysts estimated a revenue of $9.02M. Earnings per share were $-0.09. Analysts had estimated an EPS of $-0.12.

AxoGen (AXGN) made into the market gainers list on Fridays trading session with the shares advancing 1.34% or 0.12 points. Due to strong positive momentum, the stock ended at $9.07, which is also near the day’s high of $9.16. The stock began the session at $9.01 and the volume stood at 2,02,406 shares. The 52-week high of the shares is $9.16 and the 52 week low is $3.64. The company has a current market capitalization of $273 M and it has 3,01,32,224 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On Nov 12, 2015, Mark Stephen Gold (director) sold 6,013 shares at $5.70 per share price.Also, On Jun 5, 2015, Joseph M Mandato (director) purchased 6,500 shares at $3.10 per share price.On Jun 3, 2015, Lee Robert Jr Johnston (Chief Finacial Officer) purchased 5,000 shares at $3.07 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

AxoGen - Is it time to Sell?

Top Brokerage Firms are advising their investors on AxoGen. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.